{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:22:39Z","timestamp":1794558159283,"version":"4.9.1"},"reference-count":73,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1097\/01.pra.0000308491.54885.f8","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T06:27:51Z","timestamp":1236234471000},"page":"13-21","source":"Crossref","is-referenced-by-count":61,"title":["Symptoms Related to the Menstrual Cycle: Diagnosis, Prevalence, and Treatment"],"prefix":"10.1097","volume":"14","author":[{"given":"ANITA H.","family":"CLAYTON","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R4-3-20210210","first-page":"448","article-title":"ACOG Committee on Practice Bulletins-Gynecology. Premenstrual syndrome: Clinical management guidelines for obstetrician-gynecologists.","volume":"15","year":"2000","journal-title":"ACOG Pract Bull"},{"key":"R5-3-20210210","first-page":"S15","article-title":"Management strategies for PMS\/PMDD.","volume":"suppl","author":"Yonkers","year":"2004","journal-title":"J Fam Pract"},{"key":"R6-3-20210210","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00003081-199003000-00023","article-title":"Dysmenorrhea.","volume":"33","author":"Dawood","year":"1990","journal-title":"Clin Obstet Gynecol"},{"key":"R9-3-20210210","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1192\/apt.7.6.469","article-title":"Premenstrual syndrome: An update on definitions, diagnosis and management.","volume":"7","author":"Connolly","year":"2001","journal-title":"Adv Psychiatr Treat"},{"issue":"suppl 3","key":"R10-3-20210210","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0306-4530(03)00099-4","article-title":"Premenstrual syndrome and premenstrual dysphoric disorder: Definitions and diagnosis.","volume":"28","author":"Freeman","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"R11-3-20210210","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0165-1781(96)02929-0","article-title":"Reliability and validity of a daily diary for premenstrual syndrome.","volume":"65","author":"Freeman","year":"1996","journal-title":"Psychiatry Res"},{"key":"R13-3-20210210","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.jom.0000150209.44312.d1","article-title":"Estimating direct and indirect costs of premenstrual syndrome.","volume":"47","author":"Borenstein","year":"2005","journal-title":"J Occup Environ Med"},{"key":"R14-3-20210210","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.jom.0000131796.62115.84","article-title":"A prospective assessment investigating the relationship between work productivity and impairment with premenstrual syndrome.","volume":"46","author":"Dean","year":"2004","journal-title":"J Occup Environ Med"},{"issue":"suppl 3","key":"R15-3-20210210","first-page":"1","article-title":"The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS\/PMDD).","volume":"28","author":"Halbreich","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"R16-3-20210210","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2105\/AJPH.86.2.195","article-title":"Chronic gynecological conditions reported by US women: Findings from the National Health Interview Survey, 1984 to 1992.","volume":"86","author":"Kjerulff","year":"1996","journal-title":"Am J Public Health"},{"key":"R17-3-20210210","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.whi.2006.11.004","article-title":"The cost of being a woman: A national study of health care utilization and expenditures for female-specific conditions.","volume":"17","author":"Kjerulff","year":"2007","journal-title":"Womens Health Issues"},{"key":"R18-3-20210210","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/S0033291701004925","article-title":"Prevalence, incidence and stability of premenstrual dysphoric disorder in the community.","volume":"32","author":"Wittchen","year":"2002","journal-title":"Psychol Med"},{"key":"R19-3-20210210","first-page":"1007","article-title":"Visits to emergency departments for gynecologic disorders in the United States, 1992-1994.","volume":"91","author":"Curtis","year":"1998","journal-title":"Obstet Gynecol"},{"key":"R20-3-20210210","first-page":"515","article-title":"Health and economic impact of the premenstrual syndrome.","volume":"48","author":"Borenstein","year":"2003","journal-title":"J Reprod Med"},{"key":"R21-3-20210210","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1089\/jwh.1.1999.8.1043","article-title":"The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: Experience from the United States, United Kingdom and France.","volume":"8","author":"Hylan","year":"1999","journal-title":"J Womens Health Gend Based Med"},{"key":"R22-3-20210210","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1089\/jwh.2005.14.316","article-title":"Menstrual-related problems and psychological distress among women in the United States.","volume":"14","author":"Strine","year":"2005","journal-title":"J Womens Health (Larchmt)"},{"key":"R23-3-20210210","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1017\/S0033291702006074","article-title":"Short screening scales to monitor population prevalences and trends in non-specific psychological distress.","volume":"32","author":"Kessler","year":"2002","journal-title":"Psychol Med"},{"key":"R24-3-20210210","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/00023210-200317050-00003","article-title":"The role of hormones and hormonal treatments in premenstrual syndrome.","volume":"17","author":"Backstrom","year":"2003","journal-title":"CNS Drugs"},{"key":"R25-3-20210210","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199801223380401","article-title":"Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome.","volume":"338","author":"Schmidt","year":"1998","journal-title":"N Engl J Med"},{"key":"R27-3-20210210","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1517\/14656566.3.11.1577","article-title":"Pharmacotherapy of premenstrual syndromes and premenstrual dysphoric disorder: Current practices.","volume":"3","author":"Mitwally","year":"2002","journal-title":"Expert Opin Pharmacother"},{"key":"R28-3-20210210","first-page":"62","article-title":"Central serotonin and impulsive aggression.","volume":"52-","author":"Coccaro","year":"1989","journal-title":"Br J Psychiatry Suppl"},{"key":"R29-3-20210210","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.pscychresns.2006.05.002","article-title":"A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria.","volume":"148","author":"Jovanovic","year":"2006","journal-title":"Psychiatry Res"},{"key":"R30-3-20210210","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00213-006-0607-9","article-title":"Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: Findings from neuroendocrine challenge tests.","volume":"190","author":"Inoue","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"R31-3-20210210","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00737-005-0118-4","article-title":"Exploratory study of premenstrual symptoms and serotonin variability.","volume":"9","author":"Clayton","year":"2006","journal-title":"Arch Womens Ment Health"},{"key":"R32-3-20210210","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0361-9230(81)90111-8","article-title":"Effects of ovarian steroids on serotonin metabolism within grossly dissected and microdissected brain regions of the ovariectomized rat.","volume":"7","author":"Cone","year":"1981","journal-title":"Brain Res Bull"},{"key":"R33-3-20210210","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJM198903233201206","article-title":"Jr. Contraception.","volume":"320","author":"Mishell","year":"1989","journal-title":"N Engl J Med"},{"key":"R34-3-20210210","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0306-4530(94)00057-H","article-title":"Daily plasma estradiol and progesterone levels over the menstrual cycle and their relation to premenstrual symptoms.","volume":"20","author":"Redei","year":"1995","journal-title":"Psychoneuroendocrinology"},{"key":"R35-3-20210210","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/jcp.25.3.252","article-title":"Oral contraceptives and tryptophan metabolism: Effects of oestrogen in low dose combined with a progestogen and of a low-dose progestogen (megestrol acetate) given alone.","volume":"25","author":"Rose","year":"1972","journal-title":"J Clin Pathol"},{"key":"R36-3-20210210","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/archpsyc.56.10.932","article-title":"Differential response to antidepressants in women with premenstrual syndrome\/premenstrual dysphoric disorder: A randomized controlled trial.","volume":"56","author":"Freeman","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"R37-3-20210210","first-page":"285","article-title":"Dysmenorrhea.","volume":"71","author":"French","year":"2005","journal-title":"Am Fam Physician"},{"key":"R38-3-20210210","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1471-0528.1998.tb10210.x","article-title":"Efficacy of minor analgesics in primary dysmenorrhoea: A systematic review.","volume":"105","author":"Zhang","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"R39-3-20210210","first-page":"459","article-title":"Premenstrual syndrome and premenstrual dysphoric disorder: Guidelines for management.","volume":"25","author":"Steiner","year":"2000","journal-title":"J Psychiatry Neurosci"},{"key":"R40-3-20210210","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/0002-9378(89)90671-6","article-title":"Effect of nutrient intake on premenstrual depression.","volume":"161","author":"Wurtman","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"R41-3-20210210","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0002-9378(98)70377-1","article-title":"Calcium carbonate and the premenstrual syndrome: Effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group.","volume":"179","author":"Thys-Jacobs","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"R42-3-20210210","first-page":"177","article-title":"Oral magnesium successfully relieves premenstrual mood changes.","volume":"78","author":"Facchinetti","year":"1991","journal-title":"Obstet Gynecol"},{"key":"R43-3-20210210","first-page":"1239","article-title":"Diagnosis and treatment of premenstrual dysphoric disorder.","volume":"66","author":"Bhatia","year":"2002","journal-title":"Am Fam Physician"},{"key":"R44-3-20210210","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/bmj.318.7195.1375","article-title":"Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: Systematic review.","volume":"318","author":"Wyatt","year":"1999","journal-title":"BMJ"},{"key":"R45-3-20210210","first-page":"400","article-title":"Efficacy of alpha-tocopherol in the treatment of the premenstrual syndrome.","volume":"32","author":"London","year":"1987","journal-title":"J Reprod Med"},{"key":"R46-3-20210210","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00006842-199507000-00003","article-title":"Macronutrient intake, eating habits, and exercise as moderators of menstrual distress in healthy women.","volume":"57","author":"Johnson","year":"1995","journal-title":"Psychosom Med"},{"key":"R47-3-20210210","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0015-0282(16)59045-1","article-title":"Conditioning exercise decreases premenstrual symptoms: A prospective, controlled 6-month trial.","volume":"47","author":"Prior","year":"1987","journal-title":"Fertil Steril"},{"key":"R48-3-20210210","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJM199506083322301","article-title":"Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine\/Premenstrual Dysphoria Collaborative Study Group.","volume":"332","author":"Steiner","year":"1995","journal-title":"N Engl J Med"},{"key":"R49-3-20210210","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.psy.0000140005.94790.9c","article-title":"Paroxetine controlled release for premenstrual dysphoric disorder: A double-blind, placebo-controlled trial.","volume":"66","author":"Cohen","year":"2004","journal-title":"Psychosom Med"},{"key":"R50-3-20210210","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4088\/PCC.v07n0203","article-title":"Paroxetine controlled release for premenstrual dysphoric disorder: Remission analysis following a randomized, double-blind, placebo-controlled trial.","volume":"7","author":"Pearlstein","year":"2005","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"R51-3-20210210","first-page":"771","article-title":"Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria.","volume":"33","author":"Steiner","year":"1997","journal-title":"Psychopharmacol Bull"},{"key":"R52-3-20210210","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ajog.2005.01.021","article-title":"Luteal phase dosing with paroxetine controlled release (CR) in the treatment of premenstrual dysphoric disorder.","volume":"193","author":"Steiner","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R53-3-20210210","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00737-002-0162-2","article-title":"Fluoxetine improves functional work capacity in women with premenstrual dysphoric disorder.","volume":"6","author":"Steiner","year":"2003","journal-title":"Arch Womens Ment Health"},{"key":"R54-3-20210210","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1176\/appi.ajp.161.2.343","article-title":"Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder.","volume":"161","author":"Freeman","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R55-3-20210210","first-page":"1219","article-title":"Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder.","volume":"100","author":"Halbreich","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R56-3-20210210","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1001\/archfami.8.4.328","article-title":"Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study.","volume":"8","author":"Jermain","year":"1999","journal-title":"Arch Fam Med"},{"key":"R57-3-20210210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4088\/JCP.v61n0205","article-title":"Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo.","volume":"61","author":"Pearlstein","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"R58-3-20210210","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/jama.1997.03550120043031","article-title":"Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group.","volume":"278","author":"Yonkers","year":"1997","journal-title":"JAMA"},{"key":"R59-3-20210210","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4088\/JCP.v59n0206","article-title":"Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: A randomized, double-blind, placebo-controlled crossover trial.","volume":"59","author":"Young","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"R60-3-20210210","first-page":"435","article-title":"Premenstrual daily fluoxetine for premenstrual dysphoric disorder: A placebo-controlled, clinical trial using computerized diaries.","volume":"100","author":"Cohen","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R61-3-20210210","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00007611-199305000-00003","article-title":"Open trial of fluoxetine therapy for premenstrual syndrome.","volume":"86","author":"Elks","year":"1993","journal-title":"South Med J"},{"key":"R62-3-20210210","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0893-133X(94)00076-C","article-title":"The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome.","volume":"12","author":"Eriksson","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"R63-3-20210210","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/jwh.2006.15.57","article-title":"Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: The role of SSRIs.","volume":"15","author":"Steiner","year":"2006","journal-title":"J Womens Health (Larchmt)"},{"key":"R64-3-20210210","first-page":"302","article-title":"Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: The calendar of premenstrual experiences.","volume":"76","author":"Mortola","year":"1990","journal-title":"Obstet Gynecol"},{"key":"R65-3-20210210","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0149-2918(02)85043-3","article-title":"Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: A randomized, double-blind, placebo-controlled clinical trial.","volume":"24","author":"Miner","year":"2002","journal-title":"Clin Ther"},{"issue":"suppl","key":"R66-3-20210210","first-page":"S48","article-title":"Treatment regimens for managing depression in family practice.","author":"Ashton","year":"2003","journal-title":"J Fam Pract Suppl"},{"key":"R67-3-20210210","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1017\/S1461145702002870","article-title":"Emotional blunting associated with SSRI-induced sexual dysfunction. Do SSRIs inhibit emotional responses?","volume":"5","author":"Opbroek","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"R68-3-20210210","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/09513590400029584","article-title":"Algorithm for treatment of premenstrual syndromes (PMS): Experts' recommendations and limitations.","volume":"20","author":"Halbreich","year":"2005","journal-title":"Gynecol Endocrinol"},{"key":"R69-3-20210210","first-page":"303","article-title":"Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: A controlled study.","volume":"33","author":"Freeman","year":"1997","journal-title":"Psychopharmacol Bull"},{"key":"R70-3-20210210","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1055\/s-2001-18637","article-title":"Noncontraceptive benefits and therapeutic uses of the oral contraceptive pill.","volume":"19","author":"Dayal","year":"2001","journal-title":"Semin Reprod Med"},{"key":"R71-3-20210210","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0022-3999(92)90090-O","article-title":"A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive.","volume":"36","author":"Graham","year":"1992","journal-title":"J Psychosom Res"},{"key":"R72-3-20210210","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0010-7824(92)90006-F","article-title":"Oral contraceptives in premenstrual syndrome: A randomized comparison of triphasic and monophasic preparations.","volume":"46","author":"Backstrom","year":"1992","journal-title":"Contraception"},{"key":"R73-3-20210210","first-page":"261","article-title":"Hormone withdrawal symptoms in oral contraceptive users.","volume":"95","author":"Sulak","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R74-3-20210210","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0029-7844(96)00488-7","article-title":"Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms.","volume":"89","author":"Sulak","year":"1997","journal-title":"Obstet Gynecol"},{"key":"R75-3-20210210","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ajog.2004.02.012","article-title":"Manipulation of the pill-free interval in oral contraceptive pill users: The effect on follicular suppression.","volume":"190","author":"Schlaff","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R76-3-20210210","first-page":"CD004695","article-title":"Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception.","volume":"3","author":"Edelman","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"R77-3-20210210","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0010-7824(93)80141-H","article-title":"Long-interval treatment regimen with a desogestrel-containing oral contraceptive.","volume":"48","author":"Cachrimanidou","year":"1993","journal-title":"Contraception"},{"key":"R78-3-20210210","first-page":"771","article-title":"Menstrual reduction with extended use of combination oral contraceptive pills: Randomized controlled trial.","volume":"98","author":"Miller","year":"2001","journal-title":"Obstet Gynecol"},{"key":"R79-3-20210210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0010-7824(02)00445-6","article-title":"Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: A randomized trial.","volume":"67","author":"Kwiecien","year":"2003","journal-title":"Contraception"},{"key":"R80-3-20210210","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4088\/PCC.v05n0106","article-title":"Premenstrual dysphoric disorder: Recognition and treatment.","volume":"5","author":"Freeman","year":"2003","journal-title":"Prim Care Companion J Clin Psychiatry"}],"container-title":["Journal of Psychiatric Practice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00131746-200801000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T05:26:12Z","timestamp":1618032372000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00131746-200801000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/01.pra.0000308491.54885.f8","relation":{},"ISSN":["1538-1145"],"issn-type":[{"value":"1538-1145","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}